US 8591891
Monoclonal antibodies against ANGPTL4
granted A61KA61K2039/505A61P
Quick answer
US patent 8591891 (Monoclonal antibodies against ANGPTL4) held by LEXICON PHARMACEUTICALS, INC. expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- LEXICON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61P, A61P3/00, A61P3/04